Olympus Recalls Insufflator Units Over Heart Concerns, Requests No More Use Of The Device

Olympus Medical has issued a recall of its High-Flow Insufflation Unit after reports of cardiac events during surgical procedures performed while using the device. The company has also requested providers stop using the device unless no alternative is available.

RECALL
• Source: Shutterstock

Olympus Medical initiated a recall in August of some 3,000 High-Flow Insufflation Units, Model UHI-4, after reports of serious adverse events, including arrythmias and cardiac arrests. The US Food and Drug Administration labelled the recall class I, its most serious type.

There have been reports of 21 malfunctions, 10 serious injuries, and one death, according to the FDA.

More from Regulation

Planning To Take Part in MDUFA? FDA Wants To Hear From You

 

The US FDA needs to know who wants a seat at the MDUFA negotiations table before discussions can begin. The agency is asking stakeholders to let it know if they plan to participate in the periodic consultation meetings before July 28.

Finland Cracks Down On Software That Needs Regulating As A Medical Devices

 

Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it. 

Investors Urged To Prioritize Patient Engagement To Ensure Clients’ Products Succeed

 

To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.

EU Life Sciences Strategy Must Address ‘Regulatory Lasagna’

 

MedTech Europe is ready to become involved and shape Europe’s Life Sciences Strategy and help drive regulatory simplification from the top to make the EU “the world’s most attractive place for life sciences by 2030.”

More from Policy & Regulation